These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 2478718

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The expression of viral and cellular genes in papillomas of the choroid plexus induced in transgenic mice.
    Marks J, Lin J, Miller D, Lozano G, Herbert J, Levine AJ.
    Prog Clin Biol Res; 1988; 284():163-86. PubMed ID: 2851142
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice.
    Palmiter RD, Chen HY, Messing A, Brinster RL.
    Nature; 1988; 316(6027):457-60. PubMed ID: 2991771
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Renin-promoter SV40 large T-antigen transgenes induce tumors irrespective of normal cellular expression of renin genes.
    Sola C, Tronik D, Dreyfus M, Babinet C, Rougeon F.
    Oncogene Res; 1989; 5(2):149-53. PubMed ID: 2558335
    [Abstract] [Full Text] [Related]

  • 8. SV40 T-antigen induces breast cancer formation with a high efficiency in lactating and virgin WAP-SV-T transgenic animals but with a low efficiency in ovariectomized animals.
    Santarelli R, Tzeng YJ, Zimmermann C, Guhl E, Graessmann A.
    Oncogene; 1996 Feb 01; 12(3):495-505. PubMed ID: 8637705
    [Abstract] [Full Text] [Related]

  • 9. Developmental analysis of bone tumors in polyomavirus transgenic mice.
    Wang R, Siegal GP, Scott DL, Bautch VL.
    Lab Invest; 1994 Jan 01; 70(1):86-94. PubMed ID: 8302023
    [Abstract] [Full Text] [Related]

  • 10. Transgenic mice bearing the polyomavirus large T antigen directed by 2.1 kb of the keratin 19 promoter develop bronchiolar papillary tumors with progression to lung adenocarcinomas.
    Lebel M, Webster M, Muller WJ, Royal A, Gauthier J, Mes-Masson AM.
    Cell Growth Differ; 1995 Dec 01; 6(12):1591-600. PubMed ID: 9019164
    [Abstract] [Full Text] [Related]

  • 11. Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human alpha-1-antitrypsin gene.
    Sepulveda AR, Finegold MJ, Smith B, Slagle BL, DeMayo JL, Shen RF, Woo SL, Butel JS.
    Cancer Res; 1989 Nov 01; 49(21):6108-17. PubMed ID: 2551499
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
    Zhou HM, Bolon I, Nichols A, Wohlwend A, Vassalli JD.
    Cancer Res; 2001 Feb 01; 61(3):970-6. PubMed ID: 11221892
    [Abstract] [Full Text] [Related]

  • 13. Tumorigenesis in transgenic mice by a nuclear transport-defective SV40 large T-antigen gene.
    Pinkert CA, Brinster RL, Palmiter RD, Wong C, Butel JS.
    Virology; 1987 Sep 01; 160(1):169-75. PubMed ID: 2820126
    [Abstract] [Full Text] [Related]

  • 14. Tumorigenesis and eye abnormalities in transgenic mice expressing MSV-SV40 large T-antigen.
    Theuring F, Götz W, Balling R, Korf HW, Schulze F, Herken R, Gruss P.
    Oncogene; 1990 Feb 01; 5(2):225-32. PubMed ID: 2157185
    [Abstract] [Full Text] [Related]

  • 15. Differentiation and oncogenesis: phenotypically distinct lens tumors in transgenic mice.
    Nakamura T, Mahon KA, Miskin R, Dey A, Kuwabara T, Westphal H.
    New Biol; 1989 Nov 01; 1(2):193-204. PubMed ID: 2562221
    [Abstract] [Full Text] [Related]

  • 16. Progressive and regressive fate of lens tumors correlates with subtle differences in transgene expression in gamma F-crystallin-SV40 T antigen transgenic mice.
    Bryce DM, Liu Q, Khoo W, Tsui LC, Breitman ML.
    Oncogene; 1993 Jun 01; 8(6):1611-20. PubMed ID: 8389033
    [Abstract] [Full Text] [Related]

  • 17. Mouse transgenic for murine oviduct-specific glycoprotein promoter-driven simian virus 40 large T-antigen: tumor formation and its hormonal regulation.
    Miyoshi I, Takahashi K, Kon Y, Okamura T, Mototani Y, Araki Y, Kasai N.
    Mol Reprod Dev; 2002 Oct 01; 63(2):168-76. PubMed ID: 12203826
    [Abstract] [Full Text] [Related]

  • 18. T cells are responsive to the simian virus 40 large tumor antigen transgenically expressed in pancreatic islets.
    Geiger T, Soldevila G, Flavell RA.
    J Immunol; 1993 Dec 15; 151(12):7030-7. PubMed ID: 8258707
    [Abstract] [Full Text] [Related]

  • 19. The SV40 small t-antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice; truncated large T-antigen molecules harboring the intact p53 and pRb binding region do not have this effect.
    Goetz F, Tzeng YJ, Guhl E, Merker J, Graessmann M, Graessmann A.
    Oncogene; 2001 Apr 26; 20(18):2325-32. PubMed ID: 11402328
    [Abstract] [Full Text] [Related]

  • 20. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
    Green JE, Shibata MA, Shibata E, Moon RC, Anver MR, Kelloff G, Lubet R.
    Cancer Res; 2001 Oct 15; 61(20):7449-55. PubMed ID: 11606379
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.